iBio Inc. – Filings and Transcripts

NASDAQ: IBIO
Share price (5/22/26): $1.84
Market cap (5/22/26): $91.4 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q3

ended 12/31/25 Q2

ended 09/30/25 Q1 2026 – amended

ended 09/30/25 Q1

ended 06/30/25 FY 2025

Prospectuses and Registrations Filter

Prospectus supplement

Prospectus supplement for primary offering

Shelf registration

Prospectus supplement

Shelf registration

Ownership Filter

Stoner Elizabeth

Cormorant Asset Management, LP

Stoner Elizabeth

Logos Global Management LP

EcoR1 Capital, LLC

News Filter

Reports Q3 Fiscal Year 2026 Financial Results and Provides Corporate Update

Appoints Distinguished Biotech Leader, Elizabeth Stoner, to Its Board of Directors

Received Regulatory Clearance to Initiate Its Phase 1 Clinical Trial of IBIO-600 in Australia

Reports Preclinical Body Composition Data From Obese Non-Human Primates Treated With IBIO-610, a Potential First-In-Class Treatment for Fat-Selective Weight Loss

Proxies Filter

Definitive proxy

Definitive proxy

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC